January 19, 2026
According to market projections, the oncology NGS sector is expected to grow from USD 589.01 million in 2025 to USD 2538.52 million by 2035, reflecting a CAGR of 15.73%. The demand for NGS in oncology is high due to growing cases of cancer and R&...
April 21, 2026
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, ...
April 21, 2026
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing ...
April 21, 2026
According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development ...
April 21, 2026
Market insights predict, the oncology automation industry is expected to grow from USD 2.82 billion in 2024 to USD 7.77 billion by 2034, driven by a CAGR of 10.68%. The oncology automation market is growing due to rising cases of cancer, leading to a...
June 10, 2026
According to Rohan Patil, who specializes in Healthcare and Life Sciences market research and oncology diagnostics analysis, with 5+ years of experience in market research and industry analysis, the oncology biomarker market demonstrates strong expan...
March 18, 2026
According to market projections, the oncology devices sector is expected to grow from USD 177.17 billion in 2025 to USD 914.79 billion by 2035, reflecting a CAGR of 17.84%. The increasing prevalence and awareness of cancer and the shift towards perso...
April 08, 2026
Oncology Molecular Diagnostics Market ( By Type: Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer Others; By Product: Instruments, Reagents, Others; By Technology: PCR, In-situ...
April 21, 2026
Based on market forecasts, the global oncology market, projected at USD 225.05 billion in 2024, is expected to reach USD 748.17 billion by 2035, growing at a CAGR of 11.54% over the forecast period.The oncology market is expanding due to rising can...
May 18, 2026
Oncology Companion Diagnostic Market (By Product & Services: Product, Software; By Technology: Polymerase Chain Reaction, Next-generation Sequencing, Immunohistochemistry, In Situ Hybridization (ISH)/Fluorescence In Situ Hybridization, Other Tech...
May 27, 2026
Oncology Clinical Trial Market (By Phase: Phase I, Phase II, Phase III, Phase IV; By Study Design: Interventional Trials, Observational Trials, Expanded Access Trials; By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Bl...
February 17, 2026
Our projections indicate that, the oncology clinical trial monitor market was valued at USD 15.76 billion in 2026 and is projected to reach USD 25.6 billion by 2035, expanding at a CAGR of 5.54% (2026–2035)....
April 21, 2026
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
May 20, 2026
Cell and Gene Therapy for Oncology Market (By Therapy Type: Cell Therapy, Gene Therapy, Non-Viral Gene Therapy, Gene Editing Therapy; By Cancer Type: Hematological Malignancies, Solid Tumors; By Therapy Source: Autologous Therapies, Allogeneic Therap...
April 16, 2026
Orphan Oncology Market (By Therapy Type: Monoclonal Antibodies, Targeted Therapy, Immunotherapy, Chemotherapy, Cancer Vaccines; By Application: Oncology Treatment, Healthcare, Pharmaceuticals, Research, Clinical Trials; By Drug Modality: Biologi...
April 21, 2026
The global Pre-Dx oncology market is growing with rising cancer incidence and advanced early detection technologies. North America led with 45% share in 2024, while Asia Pacific is fastest-growing. Liquid biopsy tests accounted for 40% revenue, MCED ...
April 21, 2026
According to market projections, the radiation oncology sector is expected to grow from USD 12.45 billion in 2025 to USD 36.78 billion by 2035, reflecting a CAGR of 11.44%. The rising prevalence of cancer and technological advancements drive the glob...
April 21, 2026
Market insights predict the APAC clinical trials industry will increase from USD 18.87 billion in 2025 to USD 41.33 billion by 2035, achieving a CAGR of 7.16%. The market is growing due to the increasing demand for new and effective therapies and ris...
April 21, 2026
Projections indicate that, GMP peptides industry is projected to rise from USD 1.3 billion in 2024 to USD 2.9 billion by 2034, reflecting a CAGR of 8.35% over the next decade. The growing demand for peptide drugs and technological advancements drives...
February 19, 2026
According to market projections, the Europe pharmaceutical market, valued at USD 467.59 billion in 2024, is anticipated to reach USD 820.05 billion by 2034, growing at a CAGR of 5.78% over the next decade. The Europe pharmaceutical market is expandin...
April 21, 2026
Based on market forecasts, the U.S. oncology sector will expand from USD 72.79 billion in 2024 to USD 211.78 billion by 2034, experiencing a CAGR of 11.75%. The West region led the market due to the vital contribution of California in the oncology ...
June 17, 2026
According to Rohan Patil, who specializes in healthcare technology, life sciences, and AI-driven market research, with 5+ years of experience in market research and industry analysis. His research on the U.S. AI in Oncology Market reveals strong grow...
April 24, 2026
Brain Cancer Market (By Product/Solution Type: Therapeutic Treatments, Diagnostic Imaging, Surgical Devices, Supportive Care Products; By Treatment Modality: Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery, Tumor Treating Fi...
April 02, 2026
AI In Oncology Market ( By Component: Software Solutions, Hardware, Services; By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer Brain Tumors, Others; By End-User: Hospitals, Pharmaceutical Companies, Research Institutes, ...
January 06, 2026
Based on market forecasts, the bRo5 molecules market is witnessing rapid expansion due to increasing pharmaceutical R&D investments, growing adoption of AI-assisted drug discovery platforms, and rising oncology and CNS disorder prevalence. The ma...
April 21, 2026
Forecasts suggest that the non-oncology precision medicine market will expand from USD 83.87 billion in 2024 to USD 193.16 billion by 2034, with a CAGR of 8.7% during this period. Non-Oncology Precision Medicine tailors treatments to individual patie...
April 21, 2026
The veterinary oncology market reached USD 1.58 billion in 2024 and is set to grow to USD 1.77 billion in 2025, reaching USD 4.86 billion by 2034 at a CAGR of 12.14%. The report covers market segmentation by animal, therapy, and cancer type, regional...
January 16, 2026
Market insights predict, the targeted therapy industry is expected to grow from USD 85.69 billion in 2025 to USD 166.53 billion by 2035, driven by a CAGR of 6.87%. In 2024, North America led the targeted therapy market (32%), with Asia Pacific set fo...
April 21, 2026
Based on market forecasts, the U.S. oncology molecular diagnostics sector will expand from USD 810 million in 2024 to USD 2570.17 million by 2034, experiencing a CAGR of 12.24%. In 2024, breast cancer dominated the market, while liver cancer is expec...
April 21, 2026
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
April 21, 2026
Market insights predict the global clinical trial imaging industry will increase from USD 2.41 billion in 2024 to USD 5.58 billion by 2034, achieving a CAGR of 8.8%. The market is growing due to the increasing adoption of advanced imaging technologie...
May 04, 2026
Precision Oncology Market (By Product: Therapeutics, Diagnostics; By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Blood Cancer, Prostate Cancer, Others; By End-Use: Pharmaceutical & Biotechnology Companies, Hospita...
January 13, 2026
Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the to...
January 12, 2026
Projections indicate that, surgical microscope industry is projected to rise from USD 1.52 billion in 2025 to USD 4.31 billion by 2035, reflecting a CAGR of 10.97% over the next decade.Investments in healthcare infrastructure, especially in emergin...
April 21, 2026
According to market projections, the U.S. oncology drugs sector is expected to grow from USD 95.69 billion in 2024 to USD 246.85 billion by 2034, reflecting a CAGR of 9.94%. The extensive research, scientific innovations, and the market penetration...
April 21, 2026
The multiple modalities in oncology market is expanding due to increasing tumor heterogeneity as well as growing treatment approaches. North America led the market due to the presence of the advanced healthcare sector....
April 21, 2026
The microfluidics in oncology market is growing due to this system offering more sensitive and precise detection of cancer biomarkers and therapeutic approaches than traditional assays....
April 21, 2026
The rising prevalence of cancer and technological advancements are the major growth factors of the market. North America dominated the global market, owing to favorable government initiatives and increasing investments....
April 21, 2026
Market insights predict, the investigational new drug CDMO industry is expected to grow from USD 5.66 billion in 2025 to USD 11.10 billion by 2035, driven by a CAGR of 6.97%. The investigational new drug CDMO market is expanding due to increasing dev...
April 21, 2026
Rising advantages of AI and ML in the world are reducing timelines, cost-effective approaches in drug discovery and clinical trials are driving the global market. North America was dominant in the market due to technological advancements by using AI ...
May 25, 2026
Clinical Trial Services Market (By Service Line: Full-Service Clinical Development, Clinical Monitoring & Site Management, Data Management, Biostatistics & Programming, Central Lab & Biomarker Services, Functional Service Provider (FSP)/R...
May 21, 2026
AI in Oncology for Analytical Solutions Market (By Component: Data Licensing Services, Software Solutions, Analytics and Other Services; By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Kidney Cancer, Non-H...
April 21, 2026
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
April 21, 2026
Based on market forecasts, the global tele-oncology market, projected at USD 4.74 billion in 2024, is expected to reach USD 20.48 billion by 2034, growing at a CAGR of 15.76% over the forecast period. A sure sign of the adoption of advanced he...
April 21, 2026
Market insights predict the global radionuclide drug conjugates (RDC) industry will increase from USD 3.24 billion in 2024 to USD 8.87 billion by 2034, achieving a CAGR of 10.54%. The global radionuclide drug conjugates (RDC) market is growing stro...
April 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
April 21, 2026
Based on market forecasts, the global radiotherapy market, projected at USD 7.88 billion in 2024, is expected to reach USD 15.63 billion by 2034, growing at a CAGR of 7.09% over the forecast period. The market is expanding due to the increasing glo...
April 21, 2026
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
April 21, 2026
According to market projections, the immuno-oncology drugs sector is expected to grow from USD 94 billion in 2024 to USD 421.27 billion by 2034, reflecting a CAGR of 16.34%. Across the globe, a rising number of cancer patients is associated with the ...
April 21, 2026
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
+1 9197 992 333
+91 93077 85324
